Format

Send to

Choose Destination
Semin Neurol. 2017 Apr;37(2):205-214. doi: 10.1055/s-0037-1601893. Epub 2017 May 16.

Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Author information

1
Department of Neurology, University of Florida, Center for Movement Disorders and Neurorestoration, Gainesville, Florida.
2
Biomedical Engineering, University of Florida, Gainesville, Florida.

Abstract

Deep brain stimulation (DBS) is an effective therapy for Parkinson's disease patients experiencing motor fluctuations, medication-resistant tremor, and/or dyskinesia. Currently, the subthalamic nucleus and the globus pallidus internus are the two most widely used targets, with individual advantages and disadvantages influencing patient selection. Potential DBS patients are selected using the few existing guidelines and the available DBS literature, and many centers employ an interdisciplinary team review of the individual's risk-benefit profile. Programmed settings vary based on institution- or physician-specific protocols designed to maximize benefits and limit adverse effects. Expectations should be realistic and clearly defined during the evaluation process, and each bothersome symptom should be addressed in the context of building the risk-benefit profile. Current DBS research is focused on improved symptom control, the development of newer technologies, and the improved efficiency of stimulation delivery. Techniques deliver stimulation in a more personalized way, and methods of adaptive DBS such as closed-loop approaches are already on the horizon.

PMID:
28511261
PMCID:
PMC6195220
DOI:
10.1055/s-0037-1601893
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York Icon for PubMed Central
Loading ...
Support Center